Autoimmune Disease
45
10
11
24
Key Insights
Highlights
Success Rate
92% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
4.4%
2 terminated out of 45 trials
92.3%
+5.8% vs benchmark
16%
7 trials in Phase 3/4
38%
9 of 24 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 24 completed trials
Clinical Trials (45)
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
Natural History of Bronchiectasis
Safety and Preliminary Efficacy of HN2302 in Patients With Autoimmune Diseases
A Study of Safety, Tolerability, PK, and PD of Subcutaneous GenSci136 in Healthy Adults.
The 1200 Patients Project: Studying the Implementation of Clinical Pharmacogenomic Testing
Autologous Stem Cell Transplant for Neurologic Autoimmune Diseases
Remdesivir for the Treatment of Upper Respiratory Tract Infection Due to RSV in Immunocompromised Individuals
A Study of Safety, Tolerability, PK, and PD of Subcutaneous GenSci120 in Healthy Adults.
Single and Multiple Ascending Dose Study in Healthy Participants and Participants With an Autoimmune Disease
Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors
Autoimmune and Autoinflammatory Genetics Study
Autologous CD19CAR-T Therapy for Recurrent/Refractory Autoimmune Diseases
Safety and Efficacy of CD19 CAR-T Therapy for Recurrent/Refractory Autoimmune Diseases
The Safety and Efficacy of Universal CAR-T Cells Targeting BCMA in the Treatment of Refractory NMOSD
Immunogenicity of HPV Vaccine in Immunosuppressed Children
Study of a Monoclonal Antibody KHK4083 in Moderate Ulcerative Colitis
Evaluate the Safety and Tolerability of SCT650C in Healthy Volunteers
Scleroderma: Cyclophosphamide or Transplantation
Aerobic Exercise in Women With Systemic Lupus Erythematosus